InvestorsHub Logo

Theodore Vail

03/28/17 6:47 PM

#4243 RE: sorc92 #4241

Where did it say we were supposed to have results now?

December PR states;

"The study, estimated to be complete at the end of the first quarter of 2017"

Estimated....

http://www.otcmarkets.com/stock/ENDV/news/Endonovo-Evaluating-Therapeutic-Potential-of-Non-Invasive-Electroceutical-Device-Following-Myocardial-Infarction?id=147331&b=y

JDoggs_Money

03/28/17 6:48 PM

#4244 RE: sorc92 #4241

Changed? I was always under impression from company that results would be presented later in April. People are hanging too much on the Q1 thing. Just says testing completed 'around' end of Q1. Company stated April for communication a while back I read somewhere. Possible there is an issue, but I don't believe so.

tjguy

03/28/17 8:25 PM

#4264 RE: sorc92 #4241

Be careful! No posts with any hint of negativity are allowed here!

Or they are not telling the whole story with their clinicals, and need to do much more testing cause something did not go as planned.



That said, the clinical testing results coming in Q2 don't concern me that much. If "trial" finishes at the end of the Quarter, results in Q2 seem natural.